Literature DB >> 8211209

Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

S J Horning1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8211209

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  48 in total

Review 1.  Biotherapy for lymphoma.

Authors:  P McLaughlin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.075

Review 2.  Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?

Authors:  Brian K Link
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 3.  The paradox of response and survival in cancer therapeutics.

Authors:  Carol Ann Huff; William Matsui; B Douglas Smith; Richard J Jones
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 4.  Investigational strategies in autologous stem cell transplantation for follicular lymphoma.

Authors:  Oliver Weigert; Martin Dreyling; Michael Unterhalt; Wolfgang Hiddemann; Christian Buske
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 5.  Cancer stem cells: relevance to clinical transplantation.

Authors:  Gabriel Ghiaur; Jonathan M Gerber; William Matsui; Richard J Jones
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

6.  Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.

Authors:  Daryl Tan; Sandra J Horning; Richard T Hoppe; Ronald Levy; Saul A Rosenberg; Bronislava M Sigal; Roger A Warnke; Yasodha Natkunam; Summer S Han; Alan Yuen; Sylvia K Plevritis; Ranjana H Advani
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

Review 7.  Rituximab in indolent lymphomas.

Authors:  Tarek Sousou; Jonathan Friedberg
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 8.  Role of hematopoietic stem cell transplant in the management of follicular lymphoma.

Authors:  Matthew Foster; Don A Gabriel; Thomas Shea
Journal:  Oncologist       Date:  2009-06-26

Review 9.  Radioimmunotherapy-based conditioning regimens for stem cell transplantation.

Authors:  Michelle M Zhang; Ajay K Gopal
Journal:  Semin Hematol       Date:  2008-04       Impact factor: 3.851

10.  A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma.

Authors:  R Marcus; R Aultman; F Jost
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.